Evoke Pharma Inc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Evoke Pharma Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2024.
  • Evoke Pharma Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $154K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $154K Dec 31, 2024 10-K 2025-03-13
Q3 2023 $13.4K -$140K -91.3% Sep 30, 2023 10-K/A 2024-05-14
Q2 2023 $52.8K Jun 30, 2023 10-K/A 2024-05-14
Q1 2023 $91.4K Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $129K +$117K +939% Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 $154K +$105K +213% Sep 30, 2022 10-Q 2022-11-09
Q4 2021 $12.4K -$129K -91.2% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $49.1K +$13K +36% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $84.9K +$13.7K +19.3% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $120K +$14.6K +13.8% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $142K +$3.17K +2.29% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $36.1K +$717 +2.03% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $71.2K +$1.42K +2.03% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $105K +$2.1K +2.03% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $139K +$2.54K +1.87% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $35.4K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $69.8K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $103K Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $136K Jan 1, 2019 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.